Estás sin conexión — mostrando datos en caché
BibaMoney TVIJO AIOS NETWORK

Merck & Co., Inc.

MRK · NYSE
Salud · Fabricantes de Medicamentos - General
$145.27 -1.34% today
—Capitalización de mercado
—P/U (TTM)
—Margen neto
—Ingresos / acción

Acerca de Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company operating through two segments: Pharmaceuticals and Animal Health. The Pharmaceutical segment develops and markets human health products across therapeutic areas including oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes, as well as preventive vaccines for pediatric, adolescent, and adult populations. The Animal Health segment researches, develops, manufactures, and markets veterinary medicines and vaccines.

Por qué es importante

Merck is one of the largest pharmaceutical companies by revenue and is a major constituent of the healthcare sector in broad market indices. Its scale, broad therapeutic portfolio, and global vaccine and oncology franchises make it a widely followed name among investors tracking drug manufacturers. The company competes with other large-cap pharmaceutical firms across multiple therapeutic categories, and its results are influenced by patent expirations, clinical trial outcomes, regulatory decisions, and product demand.

Sitio de la empresa ↗

Cómo investigamos MRK

Fundamentos como los anteriores alimentan nuestro filtro fundamental — aceleración de EPS, ROE y momentum∧calidad — la única clase de investigación que sobrevive al walk-forward en nuestras pruebas. No emitimos objetivos de precio ni llamadas de compra/venta: consulte /edge para ver con qué rigor (y con qué poca frecuencia) algo pasa. Esta página es datos de mercado e investigación, no es asesoramiento de inversión.

Data updated 18:00 UTC, 26 Oct 2026 · source: Financial Modeling Prep via Tvijo AIOS.